Department of Microbiology and Physiological Systems; Department of Biochemistry and Molecular Pharmacology; Program in Molecular Medicine
Cancer Biology | Microbiology | Nanotechnology | Translational Medical Research
Salmonella enterica serotype Typhimurium is a food-borne pathogen that also selectively grows in tumours and functionally decreases P-glycoprotein (P-gp), a multidrug resistance transporter. Here we report that the Salmonella type III secretion effector, SipA, is responsible for P-gp modulation through a pathway involving caspase-3. Mimicking the ability of Salmonella to reverse multidrug resistance, we constructed a gold nanoparticle system packaged with a SipA corona, and found this bacterial mimic not only accumulates in tumours but also reduces P-gp at a SipA dose significantly lower than free SipA. Moreover, the Salmonella nanoparticle mimic suppresses tumour growth with a concomitant reduction in P-gp when used with an existing chemotherapeutic drug (that is, doxorubicin). On the basis of our finding that the SipA Salmonella effector is fundamental for functionally decreasing P-gp, we engineered a nanoparticle mimic that both overcomes multidrug resistance in cancer cells and increases tumour sensitivity to conventional chemotherapeutics.
Rights and Permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
DOI of Published Version
Nat Commun. 2016 Jul 25;7:12225. doi: 10.1038/ncomms12225. Link to article on publisher's site
Mercado-Lubo R, Zhang Y, Zhao L, Rossi K, Wu X, Zou Y, Castillo A, Leonard JL, Bortell R, Greiner DL, Shultz LD, Han G, McCormick BA. (2016). A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours. UMass Center for Clinical and Translational Science Supported Publications. https://doi.org/10.1038/ncomms12225. Retrieved from https://escholarship.umassmed.edu/umccts_pubs/151
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.